Cargando…
Chronic Intermittent Hypoxia Participates in the Pathogenesis of Atherosclerosis and Perturbs the Formation of Intestinal Microbiota
Chronic intermittent hypoxia (CIH) is the prominent signature of highly prevalent obstructive sleep apnea (OSA) pathophysiology, which leads to increased risk and aggravation of atherosclerotic cardiovascular diseases. However, whether intestinal microbiota is implicated in the mechanisms linking CI...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281814/ https://www.ncbi.nlm.nih.gov/pubmed/34277461 http://dx.doi.org/10.3389/fcimb.2021.560201 |
_version_ | 1783722890994122752 |
---|---|
author | Hu, Chaowei Wang, Pan Yang, Yunyun Li, Juan Jiao, Xiaolu Yu, Huahui Wei, Yongxiang Li, Jing Qin, Yanwen |
author_facet | Hu, Chaowei Wang, Pan Yang, Yunyun Li, Juan Jiao, Xiaolu Yu, Huahui Wei, Yongxiang Li, Jing Qin, Yanwen |
author_sort | Hu, Chaowei |
collection | PubMed |
description | Chronic intermittent hypoxia (CIH) is the prominent signature of highly prevalent obstructive sleep apnea (OSA) pathophysiology, which leads to increased risk and aggravation of atherosclerotic cardiovascular diseases. However, whether intestinal microbiota is implicated in the mechanisms linking CIH to arteriosclerosis (AS) pathogenesis remains unclear. The association of CIH with the development of altered gut microbiota (GM) may provide the opportunity to develop preventive strategies for atherosclerotic cardiovascular risk reduction. Animal models of apolipoprotein E-deficient (apoE(-/-)) mice treated with high-fat diet (HFD) and subjected to CIH conditions was applied to mimic the AS observed in patients with OSA. The physiological status and atherosclerotic lesion formation were confirmed by histological analysis. 16S rDNA sequencing of fecal samples was conducted to determine the changes in gut microbial composition. Morphometric analysis demonstrated that CIH caused aggravated atherosclerotic lesions and facilitated AS in apoE(-/-) mice treated with HFD. The gut bacteria was significantly varied in AS and AS+CIH mice compared with that in the control mice. Significantly perturbed GM profiles were detected in AS mice with and without CIH, with altered microbial α- and β- diversity and shifts in bacterial compositions at phylum and genus levels. While the difference between AS and AS+CIH was observed at different bacteria taxa levels. Aggravation of reduced Sutterella and increased Halomonas, Halomonadaceae and Oceanospirillales was noted in CIH-treated AS mice. The correlation of intestinal bacterial parameters with pathological changes in artery indicated complicated interactions under CIH-induced GM dysbiosis. Furthermore, the gut microbial functions in the potential ability of replication recombination and repair proteins, glycan biosynthesis and metabolism, as well as metabolism of cofactors and vitamins were identified to be further suppressed by CIH. Our findings demonstrated a causal effect of CIH on GM alterations in AS mice and suggested that the disordered GM features in AS development were deteriorated by CIH, which may be associated with AS aggravation. Preventative strategies targeting gut microbiome are highly recommended for intervention of OSA-related AS. |
format | Online Article Text |
id | pubmed-8281814 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82818142021-07-16 Chronic Intermittent Hypoxia Participates in the Pathogenesis of Atherosclerosis and Perturbs the Formation of Intestinal Microbiota Hu, Chaowei Wang, Pan Yang, Yunyun Li, Juan Jiao, Xiaolu Yu, Huahui Wei, Yongxiang Li, Jing Qin, Yanwen Front Cell Infect Microbiol Cellular and Infection Microbiology Chronic intermittent hypoxia (CIH) is the prominent signature of highly prevalent obstructive sleep apnea (OSA) pathophysiology, which leads to increased risk and aggravation of atherosclerotic cardiovascular diseases. However, whether intestinal microbiota is implicated in the mechanisms linking CIH to arteriosclerosis (AS) pathogenesis remains unclear. The association of CIH with the development of altered gut microbiota (GM) may provide the opportunity to develop preventive strategies for atherosclerotic cardiovascular risk reduction. Animal models of apolipoprotein E-deficient (apoE(-/-)) mice treated with high-fat diet (HFD) and subjected to CIH conditions was applied to mimic the AS observed in patients with OSA. The physiological status and atherosclerotic lesion formation were confirmed by histological analysis. 16S rDNA sequencing of fecal samples was conducted to determine the changes in gut microbial composition. Morphometric analysis demonstrated that CIH caused aggravated atherosclerotic lesions and facilitated AS in apoE(-/-) mice treated with HFD. The gut bacteria was significantly varied in AS and AS+CIH mice compared with that in the control mice. Significantly perturbed GM profiles were detected in AS mice with and without CIH, with altered microbial α- and β- diversity and shifts in bacterial compositions at phylum and genus levels. While the difference between AS and AS+CIH was observed at different bacteria taxa levels. Aggravation of reduced Sutterella and increased Halomonas, Halomonadaceae and Oceanospirillales was noted in CIH-treated AS mice. The correlation of intestinal bacterial parameters with pathological changes in artery indicated complicated interactions under CIH-induced GM dysbiosis. Furthermore, the gut microbial functions in the potential ability of replication recombination and repair proteins, glycan biosynthesis and metabolism, as well as metabolism of cofactors and vitamins were identified to be further suppressed by CIH. Our findings demonstrated a causal effect of CIH on GM alterations in AS mice and suggested that the disordered GM features in AS development were deteriorated by CIH, which may be associated with AS aggravation. Preventative strategies targeting gut microbiome are highly recommended for intervention of OSA-related AS. Frontiers Media S.A. 2021-07-01 /pmc/articles/PMC8281814/ /pubmed/34277461 http://dx.doi.org/10.3389/fcimb.2021.560201 Text en Copyright © 2021 Hu, Wang, Yang, Li, Jiao, Yu, Wei, Li and Qin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Hu, Chaowei Wang, Pan Yang, Yunyun Li, Juan Jiao, Xiaolu Yu, Huahui Wei, Yongxiang Li, Jing Qin, Yanwen Chronic Intermittent Hypoxia Participates in the Pathogenesis of Atherosclerosis and Perturbs the Formation of Intestinal Microbiota |
title | Chronic Intermittent Hypoxia Participates in the Pathogenesis of Atherosclerosis and Perturbs the Formation of Intestinal Microbiota |
title_full | Chronic Intermittent Hypoxia Participates in the Pathogenesis of Atherosclerosis and Perturbs the Formation of Intestinal Microbiota |
title_fullStr | Chronic Intermittent Hypoxia Participates in the Pathogenesis of Atherosclerosis and Perturbs the Formation of Intestinal Microbiota |
title_full_unstemmed | Chronic Intermittent Hypoxia Participates in the Pathogenesis of Atherosclerosis and Perturbs the Formation of Intestinal Microbiota |
title_short | Chronic Intermittent Hypoxia Participates in the Pathogenesis of Atherosclerosis and Perturbs the Formation of Intestinal Microbiota |
title_sort | chronic intermittent hypoxia participates in the pathogenesis of atherosclerosis and perturbs the formation of intestinal microbiota |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281814/ https://www.ncbi.nlm.nih.gov/pubmed/34277461 http://dx.doi.org/10.3389/fcimb.2021.560201 |
work_keys_str_mv | AT huchaowei chronicintermittenthypoxiaparticipatesinthepathogenesisofatherosclerosisandperturbstheformationofintestinalmicrobiota AT wangpan chronicintermittenthypoxiaparticipatesinthepathogenesisofatherosclerosisandperturbstheformationofintestinalmicrobiota AT yangyunyun chronicintermittenthypoxiaparticipatesinthepathogenesisofatherosclerosisandperturbstheformationofintestinalmicrobiota AT lijuan chronicintermittenthypoxiaparticipatesinthepathogenesisofatherosclerosisandperturbstheformationofintestinalmicrobiota AT jiaoxiaolu chronicintermittenthypoxiaparticipatesinthepathogenesisofatherosclerosisandperturbstheformationofintestinalmicrobiota AT yuhuahui chronicintermittenthypoxiaparticipatesinthepathogenesisofatherosclerosisandperturbstheformationofintestinalmicrobiota AT weiyongxiang chronicintermittenthypoxiaparticipatesinthepathogenesisofatherosclerosisandperturbstheformationofintestinalmicrobiota AT lijing chronicintermittenthypoxiaparticipatesinthepathogenesisofatherosclerosisandperturbstheformationofintestinalmicrobiota AT qinyanwen chronicintermittenthypoxiaparticipatesinthepathogenesisofatherosclerosisandperturbstheformationofintestinalmicrobiota |